Genecast Biotechnology is a China-based biotech startup focused on next-generation sequencing (NGS) technology and bioinformatics. The company develops NGS and bioinformatics solutions for applications in biotechnology and life sciences. The article describes Genecast as Matrix-backed. Genecast closed a Series D1 financing round totaling 300 million yuan (approximately $43 million). The round was led by CICC Capital, the investment platform of China International Capital Corporation. No operating metrics or future product plans were disclosed in the article.

Total raised

$42M

Funding rounds

1

Latest round

Series D

Latest activity

Oct 2019